The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 15th 2025
A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.
CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes
From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.
Read More
CHAPTER 4. Guideline for the Care of the Older Adult With Diabetes
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts. This guideline was revised and approved May 17, 2017, and updated February 7, 2018.
Read More
CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
Read More
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Read More
CHAPTER 1. Clinical Guideline for Adults With Diabetes
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Read More
Clinical Oversight Committee, Joslin Diabetes Center
June 22nd 2018Listed below are members of the Clinical Oversight Committee and Working Groups who participated in development of the Clinical Guidelines for Joslin Diabetes Center. Faculty who participated in guideline development who are no longer at Joslin are designated with an asterisk.
Read More
From the Editors: Bringing the Joslin Clinical Guidelines to the Diabetes Care Community
June 22nd 2018Om P. Ganda, MD, serves as chair of the Joslin Clinical Oversight Committee, and Robert A. Gabbay, MD, PhD, FACP, is senior vice president and chief medical officer of Joslin Diabetes Center.
Read More
This Week in Managed Care: June 22, 2018
June 22nd 2018This week in managed care, the top stories included Atul Gawande, MD, being named the CEO of the Amazon–Berkshire Hathaway–JPMorgan Chase healthcare venture; the Trump administration finalized rules for creating association health plans; an analysis found some cancer types are represented more than others in the Oncology Care Model.
Watch
Recent-Onset Diabetes May Be a Sign of Pancreatic Cancer in African American, Latino Adults
June 20th 2018While receiving a diagnosis of type 2 diabetes is common for US adults, African American and Latino adults over age 50 who receive a new diabetes diagnosis may have another health issue to be concerned about: pancreatic cancer.
Read More
If you heard of a drug with a 387 percent return on investment, wouldn’t you want in? That was the result of a voluntary program in Maine that provided proper meals to high-risk Medicare patients leaving the hospital. Managed Care Cast explores results that appear in the current issue ofThe American Journal of Managed Care®.
Read More
Prevalence and Predictors of Hypoglycemia in South Korea
The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database.
Read More
This Week in Managed Care: June 1, 2018
June 1st 2018This week, the top managed care stories include Senator Bill Cassidy's new plan to lower healthcare costs; policy recommendations from the American Diabetes Association on how to lower insulin prices; and coverage from the American Society of Clinical Oncology annual meeting.
Watch
This Week in Managed Care: May 25, 2018
May 25th 2018This week, the top managed care stories include the finding that new guidelines will mean the number of people with hypertension will soar; research finds that most diabetes apps don’t lower glycated hemoglobin; and a health plan announced its plan to fight housing instability.
Watch
ADA Issues Recommendations Designed to Fix Insulin Pricing, Accessibility Crisis
May 25th 2018The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication. The recommendations follow the findings of a working group about the issue, the findings of which were presented to the Special Senate Committee on Aging earlier this month.
Read More